• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR ABSORB; BIORESORBABLE SCAFFOLD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR ABSORB; BIORESORBABLE SCAFFOLD Back to Search Results
Catalog Number UNK ABSORB
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Intimal Dissection (1333)
Event Date 12/01/2017
Event Type  Injury  
Manufacturer Narrative
Udi # - in the absence of reported part number, udi could not be provided.Exemption number (b)(4).There was no reported device malfunction and the product was not returned as the scaffold remains in the anatomy.A review of the lot history record and complaint history of the reported lot could not be conducted because the part and lot number were not provided.Based on the case information a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.The reported patient effect of dissection, as listed in the bioresorbable vascular scaffold (bvs) system, absorb, instructions for use is a known adverse event associated with the use of a coronary scaffold in native coronary arteries.There is no indication of a product quality issue with respect to design, manufacture or labeling of the device.Attached, article title: "acute angiographic and intermediate-term clinical results of patients with non-left main coronary bifurcation lesions treated with bvs by jailed semi-inflated balloon technique and provisional side-branch stenting strategy." the absorb device is currently not commercially available in the u.S; however, it is similar to a device sold in the us.
 
Event Description
It was reported through a research article that the abbott bioresorbable vascular scaffold may be related to some dissections that occurred during the coronary procedure.Details are listed in the attached article, titled acute angiographic and intermediate-term clinical results of patients with non-left main coronary bifurcation lesions treated with bvs by jailed semi-inflated balloon technique and provisional side-branch stenting strategy.
 
Manufacturer Narrative
This report is being resubmitted to ensure the enclosed attachment can be easily opened by the fda.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ABSORB
Type of Device
BIORESORBABLE SCAFFOLD
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key9377412
MDR Text Key168058736
Report Number2024168-2019-13926
Device Sequence Number1
Product Code PNY
Combination Product (y/n)Y
PMA/PMN Number
P150023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Type of Report Initial,Followup
Report Date 07/29/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/26/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK ABSORB
Was Device Available for Evaluation? No
Date Manufacturer Received07/20/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age59 YR
-
-